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UNILATERAL 
THORACOSCOPIC 
SURGICAL APPROACH 
FOR DIFFUSE EMPHYSEMA 
We evaluated the use of a lateral thoracoscopic approach for lung reduction 
surgery in patients with diffuse emphysema. Sixty-seven patients with a 
mean age of 61.9 years underwent operation. Operative side was deter- 
mined by preoperative imaging. The procedures were laser ablation in 10 
patients and stapler esection in 57 patients. Ten patients, including six of 
the 10 patients in the laser-only group had poor outcome (death or 
hospitalization longer than 30 days), leading us to abandon the laser 
technique. Of the remaining 57 patients undergoing primary stapled 
resection, duration of chest ube placement averaged 13 days (range 3 to 53 
days) with a mean hospital stay of 17 days (range 6 to 99 days). Seven 
patients required ventilation for longer than 72 hours, six patients under- 
went conversion of the procedure to open thoracotomy, four patients 
acquired arrhythmias, and three patients were treated for empyema. There 
was one early death (1.7%), from cardiopuimonary failure. Forty patients 
returned for 3-month evaluation. Significant (p < 0.0001) improvements 
were seen in forced vital capacity (2.69 L after vs 2.26 L before) and forced 
expiration volume in 1 second (1.04 L after vs 0.82 L before), with 25 of 40 
patients (63%) showing an improvement of more than 20%. Lung volume 
measures, in particular esidual volume, fell significantly. Arterial blood 
gas analysis revealed that carbon dioxide tension fell significantly in 
patients with preoperative hypercapnia (carbon dioxide tension >45 mm 
Hg, p = 0.018). Six-minute walk test results improved (894 feet after vs 784 
feet before, p = 0.002), and symptomatic benefit was confirmed by 
significant improvement in the dyspnea index. The combination of both 
hypercapnia and reduced single-breath diffusing capacity for carbon mon- 
oxide was significantly more frequent (p = 0.0026) and was 86% specific (5 
of 6 patients) in predicting serious postoperative risk. We conclude that the 
lateral thoracoscopic surgical approach to diffuse emphysema offers signif- 
icant improvement in pulmonary mechanics and functional impairment. 
Patients with a combination of hypercapnia nd reduced single-breath 
diffusing capacity for carbon monoxide should not be considered for this 
procedure because of significant perioperative risk. (J THORAC CARDIOVASC 
SURG 1996;111:308-16) 
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C hronic obstructive lung disease is America's number-three killer, accounting for one in seven 
deaths. In 1990, the National Health Interview 
Survey estimated the nationwide prevalence of em- 
physema at 2 million cases. More than 42% of 
persons with emphysema have limitations in activi- 
ties of daily living. ~ The progression of emphysema 
is insidious, and severe symptoms may not develop 
for many years. Most patients die within 2 years 
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after medical treatment has become ineffective. 
Lung transplantation can help only a relative few, 
and many patients with emphysema are beyond the 
age limits for transplantation candidacy. 
Excision of large bullae, occupying at least one 
third of the volume of the affected lung, is well 
established for relief of compression causing dys- 
pnea. 2 More recently, however, attention has fo- 
cused on the potential benefits of surgical resection 
of diffusely emphysematous ti sue in an effort to 
reduce dyspnea and improve exercise tolerance. 
This effort is based on the pioneering work of 
Brantigan, Kress, and Mueller, 3 who postulated that 
denervation of the lung and removal of wedges of 
diseased tissue to reduce the overall volume of the 
lung and reshape its configuration would improve 
the elastic recoil of small airways and improve 
diaphragmatic excursion. This early experiment was 
successful in some patients, but the considerable 
morbidity associated with the standard thoracotomy 
technique led to abandonment of the procedure. 
Video-assisted thoracic surgery has been increas- 
ingly used for a number of pulmonary surgical 
interventions. This approach, which avoids the ne- 
cessity for thoracotomy, has significantly reduced 
morbidity otherwise accompanying surgical inter- 
vention for selected pulmonary problems. 4 Use of 
video-assisted thorascopic laser ablation to treat 
bullous emphysema has been reported, s Wakaba- 
yashi and coworkers 6 first described its use for 
diffuse emphysema in a small group of patients, 
although the perioperative complication rate was 
significant] Results from this series indicated sub- 
jective relief of symptoms in most patients and 
significant improvement in a small subgroup with 
respect to pulmonary function and exercise toler- 
ance. More recently, Cooper and associates s re- 
ported on 20 patients who, after median sternotomy 
and stapled resection of emphysematous ti sue, had 
improvements in pulmonary function and symp- 
toms, with an average increase in forced expiratory 
volume in 1 second (FEVI) of 82% over preopera- 
tive values. 
We undertook this study to evaluate the efficacy 
of a unilateral thoracoscopic approach to lung re- 
duction surgery. The aims of the study were to 
determine the effectiveness of thoracoscopic laser 
and stapled ablation in improving pulmonary func- 
tion and reducing symptoms, and to investigate the 
physiologic mechanisms by which this improvement 
is achieved. A further aim was to evaluate the 
prognostic value of preoperative physiologic and 
anatomic selection factors. 
Methods 
Patient population. Sixty-seven adults with diffuse em- 
physema were enrolled in this study. The participants all 
had end-stage emphysema,  severely impaired quality of 
life despite maximal medical therapy, and disabling dys- 
pnea at less than 50 yards of walking. Patients with bullous 
emphysema whose disease was characterized by large 
bullae with compressive signs on computed tomographic 
(CT) scan were excluded from the study. Fourteen candi- 
dates had been evaluated by the lung transplantation 
program and were offered lung reduction surgery as an 
alternative or as a bridge to transplantation. All patients 
were receiving maximal bronchodilator therapy, with 18 
subjects also taking regular doses of prednisone. Supple- 
mental oxygen therapy was required by 80% of our 
candidates, with 62% of all patients using oxygen contin- 
uously. 
Exclusion criteria included known pulmonary hyperten- 
sion (systolic pulmonary arterial pressure >60 mm Hg), 
smoking of tobacco products within the last 3 months, 
morbid obesity (>1.5 lean body weight), unstable coro- 
nary artery disease, end-stage cancer, nonambulatory sta- 
tus, and ventilator-dependence. Patients who had previ- 
ously undergone open thoracic surgical procedures on the 
side designated for lung reduction were also excluded. 
Subjects who had undergone previous contralateral tho- 
racic surgery or cardiac procedures through a median 
sternotomy remained eligible for the unilateral thoraco- 
scopic approach. 
All patients were seen in consultation by the nutrition 
service for assessment of nutritional status and recom- 
mendations for supplementation. Patients who were tak- 
ing more than 20 rag/day of prednisone were not eligible 
for operation until they were weaned below this level. All 
patients were encouraged toparticipate in a cardiopulmo- 
nary rehabilitation program for a minimum of 2 months, 
but this was not a requirement of the program. 
The study was approved by the University of Pittsburgh 
Institutional Review Board for Biomedical Research. 
Pulmonary evaluation. Standard preoperative studies 
to evaluate patients with poor pulmonary reserve were 
performed. Testing was conducted 1 to 3 weeks before 
operation. These studies included apreoperative electro- 
cardiogram, routine blood work (arterial blood gases; 
complete blood cell count; serum chemistry profile; and 
coagulation profile including prothrombin time, partial 
thromboplastin ime, thromboplastin me, and platelets), 
posterior-anterior and lateral chest roentgenograms, and 
two-dimensional echocardiography to assess global ven- 
tricular function. 
Standard pulmonary function tests including spirometry 
to measure actual, predicted, and percentage ofpredicted 
forced vital capacity (FVC), FEV1, FEV1/FVC ratio, 
forced expiratory flow at 25% to 75% of FVC, peak 
expiratory flow, and maximal voluntary ventilation were 
conducted and the results were recorded. 9 The single- 
breath diffusing capacity for carbon monoxide (DLCO) 
and maximal respiratory pressures were also deter- 
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Table I. Assessment offunctional impairment with 
dyspnea indexes 
Baseline dyspnea index (BDI) 
Functional impairment 
Grade 4 No impairment. Able to carry out usual 
activities and occupation without short- 
ness of breath. 
Grade 3 Slight impairment. Distinct impairment in
at least one activity but no activities 
completely abandoned. Reduction in 
activity at work or in usual activities 
seems light or not clearly caused by 
shortness ofbreath. 
Grade 2 Moderate impairment. Patient has 
changed jobs and/or abandoned atleast 
one usual activity because of shortness 
of breath. 
Grade 1 Severe impairment. Patient unable to 
work or has given up most or all usual 
activities because of shortness of
breath. 
Grade 0 Very severe impairment. Unable to work 
and has given up most or all usual ac- 
tivities because of shortness of breath. 
Transitional dyspnea index (TDI) 
Change in functional impairment 
-3 Major deterioration. Formerly working 
-2 
-1 
0 
+1 
+2 
+3 
and has had to stop working and has 
completely abandoned some usual ac- 
tivities because of shortness of breath. 
Moderate deterioration. Formerly working 
and has had to stop working or has 
completely abandoned some usual ac- 
tivities because of shortness of breath. 
Minor deterioration. Has changed to a 
lighter job and/or has reduced activities 
in number or duration because of 
shortness of breath. Any deterioration 
less than preceding categories. 
No change. No change in functional status 
because of shortness ofbreath. 
Minor improvement. Able to return to 
work at reduced pace or has assumed 
some customary activities with more 
vigor than previously because of im- 
provement inshortness ofbreath. 
Moderate improvement. Able to return to 
work at nearly usual pace and/or able 
to return to most activities with moder- 
ate restriction only. 
Major improvement. Able to return to 
work at former pace and able to return 
to full activities with only minor restric- 
tion because of improvement i  short- 
ness of breath. 
mined. 1° Body plethysmography was used to measure 
thoracic gas volumes functional reserve capacity, total 
lung capacity (TLC), and residual volume. 11 
CT scans of the chest were performed with l0 mm 
slices obtained every l0 mm with a GE HiSpeed Advan- 
tage scanner (General Electric CGR USA, Milwaukee, 
Wis.). Images were filmed at a window of 1500 and a level 
of -600. Density mask images were obtained by highlight- 
ing voxels that corresponded to -910 to -1024 
Hounsfield units with a standard GE density mask pro- 
gram. This range has been shown to correspond to 
emphysema in pathologic specimens 12and with estimates 
of pulmonary function. Ventilation and perfusion scans 
were obtained in which segmental quantitation of venti- 
lation and perfusion were calculated to establish baseline 
function. Single photon-emission CT (SPECT) perfusion 
imaging was performed with a dual-head gamma camera. 
The studies were obtained in a 128 matrix in word mode. 
A 1.6 acquisition zoom at 3 degrees of angular sampling 
with a noncircular orbit for 20 minutes was used. The data 
were reconstructed by means of a Hanning filter with a 
cutoff requency of 1.3 cycles/cm and axial smoothing. The 
transaxial data were reprojected into 36 frames by means 
of volume-rendering with a linear maximal value tech- 
nique. 14 Images were viewed in a rotating display mode. 
This three-dimensional image of the lungs assisted in 
determining the areas to be resected. 
Exercise capacity was tested with a 6-minute walk 
monitored by pulse oximetry. Supplemental oxygen was 
titrated before the testing maneuver to determine a flow 
rate that would maintain oxygen saturation above 90% 
during usual pace exertion. Patients were given a standard 
set of instructions before the maneuver, and no coaching 
was provided uring the testing. 
The degree of functional impairment from dyspnea was 
determined by use of the baseline dyspnea index. 15 One of 
the investigators selected from one to five grades of 
dyspnea on the basis of an extensive history (Table I). 
Three months after operation, pulmonary function, 
diagnostic imaging, and the 6-minute walk were repeated 
to evaluate the extent of improvement and to determine 
the mechanisms involved. Patients and technicians were 
blinded to the preoperative values during postoperative 
testing. Changes in the degree of functional impairment 
after surgery was determined at the 3-month study point 
by means of a transitional dyspnea index (TDI). A TDI 
score, ranging from -3  (major deterioration) to +3 
(major improvement), was assigned after an extensive 
interview (Table I). 
Operative procedure. Electrocardiographic monitor- 
ing, radial arterial cannulation, and central venous access 
for monitoring of pulmonary artery pressures and cardiac 
output were routine in all cases. An epidural catheter was 
placed in a low thoracic position to provide postoperative 
analgesia nd also to augment the intraoperative anes- 
thetic management. This strategy was aimed at reducing 
inhalational anesthetic and systemic narcotic require- 
ments during the procedure. 
Selective airway intubation was accomplished with a 
left-sided double-lumen endotracheal tube. Preparation 
for high-frequency jet ventilation was made in case that 
ventilatory method were to become necessary during the 
lung reductive procedure. Pulse oximetry and end-tidal 
carbon dioxide monitoring were followed throughout the 
procedure. Baseline arterial blood gas values and cardiac 
output were obtained before the incision. 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 111, Number 2 
Keenan et al. 3 11 
Fig. 1. CT images, as normally generated (left) and with density mask imaging (right) to demonstrate more 
dearly the areas of anatomic emphysema (shown in white). 
Lung reduction was performed on the lung most se- 
verely affected by the emphysematous process, as deter- 
mined roentgenographically (by chest radiograph, CT 
scan, and ventilation and SPECT perfusion uclear scin- 
tigraphy). The areas of the lung to be resected uring the 
lung reduction procedure were also primarily determined 
by the preoperative roentgenographic findings. In partic- 
ular, the density mask images of the CT scan highlighted 
the areas of worst anatomic disease, as well as zones of 
more normal ung (Fig. 1), whereas the SPECT perfusion 
study demonstrated zones of significant hypoperfusion. 
These areas were focused on during the resection, partic- 
ularly when the ventilation studies had shown associated 
washout abnormalities. 
The patient was placed in a full lateral decubitus 
position. A three- to five-port intercostal ccess technique 
was used in most circumstances. The access for the 
"operative" thoracoscope was achieved in the seventh to 
eighth intercostal space at the mid to posterior axillary 
line. After intercostal access for the thoracoscope was 
established, subsequent sites of access for instrumentation 
were achieved in the sixth or seventh interspace in the 
posterior axillary line and in the seventh interspace in the 
anterior axillary line. 
In 10 patients, laser ablation of emphysematous ti sue 
was the sole modality of lung reduction. In these patients, 
the areas of significant disease were diffusely scarified with 
the neodymium:yttrium-aluminum-garnet (Nd:YAG) la- 
ser, set at 10 to 15 watts in the noncontact mode. 
Endoscopic stapler resection of portions of the lung 
became the preferred approach, with either a 30 mm 
(United States Surgical Corp., Norwalk, Conn.) or a 60 
mm (Ethicon Endo-Surgery, Cincinnati, Ohio) stapler 
used. Areas of bullous formation located near the pulmo- 
nary hilum or at angles difficult to reach with the endo- 
scopic stapler were managed with Nd:YAG laser bullous 
ablation. Similarly, areas of "vanishing lung," consoli- 
dated areas of numerous bullae, were initially scarified 
and reduced with laser energy before stapler application. 
In practice, about 90% of the lung reduction in any patient 
was accomplished with the endoscopic stapler, with the 
noncontact Nd:YAG laser being required sparingly. The 
lung resection was aimed at reducing the overall volume 
of the lung by 25%. Strips of lung tissue were resected 
along the leading edges of each lobe, such as along the 
fissures or anteriorly and posteriorly to the apex of the 
upper lobe and along the basal segments or superior 
segment of the lower lobe. The extent of resection in each 
area was determined inadvance by the results of the SPECT 
perfusion studies. The lung was partially inflated periodically 
during the procedure to estimate the extent of resection 
accomplished in each lobe of the lung and thus gauge the 
progress of the procedure to avoid overresection. 
At the termination f the procedure, three chest tubes 
were strategically placed into the pleural cavity through 
the intercostal access used during the operative interven- 
tion. Two tubes were positioned at the apex, and a single 
right-angle tube was placed in the costophrenic angle. The 
lung was gently reexpanded and ventilation was reestab- 
lished, with the aim of keeping peak airway pressures at 
the minimum required to achieve an adequate tidal 
volume (less than 30 mm Hg). Air leakage from the chest 
tubes was assessed before the surgical field was taken 
down. To avoid an excessive pressure gradient and possi- 
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Fig. 2. Histogram demonstrating the range of improve- 
ment in postoperative FEV1 demonstrated by patients at 
3-month evaluation. 
ble overdistention ofthe remaining lung, chest ubes were 
placed on only -10 cm H20 of suction. After 24 hours, 
adjustments were made as necessary. 
Patients were maintained on ventilatory assistance as 
needed. Our aim, however, was to achieve arly postop- 
erative xtubation and independent ventilation as soon as 
possible after operation. 
The incidences of postoperative complications were 
documented. Complications assessed included death, 
pneumonia, duration of air leaks, empyema, respiratory 
failure requiring prolonged ventilation, and cardiovascu- 
lar complications. 
Statistics and analysis. Data are expressed a mean _+ 
standard error of the mean. Student's t tests for paired 
samples were used to examine changes in spirometry 
measurements, lung volumes, arterial blood gases, and 
6-minute walk results. Fisher's Exact Test and X 2 tests 
were used to examine the differences between risk groups. 
Results were considered significant for p less than 0.05. 
Results 
There were 24 female and 43 male patients, with 
an average age of 61.9 + 8.1 years (range 36 to 78 
years). Operative procedure was pure laser ablation 
in 10 patients (laser group). The stapler group 
comprised the following procedures: stapled resec- 
tion in 23 patients and stapler esection with modest 
laser ablation in 34 patients. In the latter group, less 
than 2500 J laser energy was used in any single case. 
Fifty-nine of the 67 patients were extubated in the 
operating room or within 2 hours of arrival in the 
intensive care unit. The remaining patients were 
extubated between 2 and 60 days after operation, 
Laser group. Analysis of the patients in the laser 
group revealed that six of the 10 patients in whom 
the laser was the predominant operating tool had 
adverse outcomes. Two patients died in the postop- 
erative period, and four additional patients had 
hospitalizations longer than 30 days for cardiopul- 
monary complications. This experience led us to 
Table II. Complications of stapler or stapler-laser 
lung reduction surgery 
Complication No. of patients 
Air leak >5 days 31 
Ventilation >72 hr 7 
Conversion toopen th0racotomy 6 
Dysrhythmias 4 
Empyema 3 
Pneumonia 2 
Stroke 1 
Ischemic colitis 1 
abandon the laser ablation technique in favor of 
stapled resection. The patients in the laser group are 
not included in the remaining analyses except for 
the analysis of predictors of poor outcome. 
Stapler group. Among the 57 patients in the 
stapler group, there were two postoperative deaths 
(3,4%). In addition there were three late deaths 
(longer than 4 months after operation), one each 
from pneumonia, stroke, and myocardial infarction. 
Four patients, including one of those accounting for 
the late deaths, had prolonged hospitalizations, 
ranging from 41 to 139 days. 
Length of hospital stay averaged 17 _+ 11.1 days. 
The most common complication was air leakage 
lasting beyond 5 days (Table II). The average dura- 
tion of chest ube placement was 13 + 9.4 days, with 
a range of 3 to 53 days. Intraoperative air leakage 
necessitated immediate conversion of the procedure 
to open thoracotomy in six patients. Three patients 
had postoperative mpyemas, all of which were 
successfully managed with chest tube drainage. 
Among the survivors, follow-up testing was per- 
formed at 3 months on 40 patients. Of the remaining 
12 patients, five are scheduled for return visits at 6 
months because of travel distance, one patient who 
had a postoperative stroke was not able to complete 
the full testing, one patien t was found to have an 
unrelated cancer and is undergoing therapy, and 
one patient is not available for follow-up. Four other 
patients have refused 3-month follow-up testing. 
Physiologic studies. The mean preoperative 
FEV 1 was 0.82 L, representing 30% of the predicted 
value. At 3-month follow-up, the mean FEV 1 had 
risen significantly (p < 0.0001), to 1.04 L or 39% of 
predicted (Table III). Thirty-four patients (85%) 
had improvement from preoperative values, with an 
average increase of 38%. Fourteen patients (35%) 
demonstrated improvements of greater than 40%, 
ranging from 40% to 149%, whereas six patients 
(15%) showed no benefit from the procedure (Fig. 
2). Similar improvements in FVC were noted after 
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Table III. Changes in spirometry and lung volume measurements after lung reduction surgery 
Before operation 3 months 
Value % Predicted Value % Predicted p 
FEV 1 (L) 0.82 ± 0.05 30 1.04 -+ 0.06 39 <0.0001 
FVC (L) 2.26 ± 0.14 58 2.69 ± 0.15 70 <0.0001 
TLC (L) 7.9 + 0.3 139 7.4 ± 0.3 129 <0.0001 
RV (L) 5.1 ± 0.2 239 4.3 -+ 0.2 202 <0.0001 
RV/TLC ratio 0.64 0.58 <0.0001 
DLCO 38.1 ±_ 2.5 42.4 ± 2.2 0.018 
Data mean -+ SEM. 
the lung reduction procedure. TLC, functional re- 
sidual capacity, and RV all showed significant (p < 
0.0001) declines after operation (Table II). The 
magnitude of the fall in RV, however, was greater 
than the reduction in TLC, as indicated by the 
RV/TLC ratio, which declined from 0.64 before 
operation to 0.58 (p < 0.0001) at 3 months after 
operation. The DLCO was also significantly im- 
proved after operation, from 38% before operation 
to 42% after operation (p = 0.018). 
The room air oxygen tension did not change after 
operation; itwas 64 mm Hg before and 65 mm Hg at 
3 months after operation. There was a slight but 
significant (p = 0.034) decline in carbon dioxide 
tension (Pco2), from 43 _+ 7 mm Hg before opera- 
tion to 40 _+ 8 mm Hg at 3 months after operation. 
This improvement was more dramatic in the 12 
patients who initially had hypercapnia (Pco2 >45 
mm Hg). In this subgroup of patients, whose Pco2 
ranged from 46 to 62 mm Hg, the mean Pco2 fell 
from 50.5 to 45 mm Hg after operation (p = 0.018). 
Functional measures. After operation, patients 
demonstrated functional improvement by walking 
further in the 6-minute walk test. Mean walk dis- 
tance rose from 784 _+ 51 feet before operation to 
894 _+ 49 feet at 3-month testing (p = 0.002). 
Subjective stimates of functional impairment by 
means of the preoperative baseline dyspnea index 
averaged 1.3, indicating severe impairment. Three 
months after operation patients indicated a moder- 
ate improvement of symptoms, with a mean TDI of 
1.7. Assessment of the TDI provided a method to 
determine whether there were any subjective dif- 
ferences between the patients who returned for 
3-month evaluation and those who did not. Tele- 
phone interviews conducted with the latter group 
revealed a mean TDI score of 1.4, which was not 
significantly different from that of the returning 
cohort of patients. 
The need for supplemental oxygen was eliminated 
in 17% of patients at 3-month follow-up. An addi- 
tional 25% of patients had reduced oxygen require- 
ments during exercise. 
Predictors of poor outcome. An interim analysis 
of the first 42 patients, including all 10 who under- 
went laser ablation only and the first 32 patients to 
undergo stapler or stapler-laser procedures, was 
performed to determine whether any preoperative 
variables were predictive for adverse outcome after 
lung reduction. An adverse outcome was defined as 
in-hospital death or as hospitalization longer than 
30 days for cardiopulmonary complications. Ten 
patients demonstrated hypercapnia (Pco2 -> 50 mm 
Hg) on the preoperative arterial blood gas analysis; 
six of these patients (60%) had poor outcome, 
compared with only 17.9% (5/28) of the remaining 
evaluable patients (p = 0.0193). A similar number of 
patients (10) demonstrated a reduced (--25%) 
DLCO; again, the risk of a poor outcome was 
significantly higher (p = 0.0193) among these sub, 
jects (60%) than among patients without this risk 
factor. Of particular importance was the finding that 
the combination of hypercapnia and reduced DLCO 
was 86% specific (five of six patients) in predicting 
serious postoperative risk (p = 0.0026). All subse- 
quent patients referred for unilateral thoracoscopic 
lung reduction were not operated on if they had this 
combination of characteristics. 
Discussion 
The traditional indication for bullectomy, removal 
of dominant bullae with reexpansion of previously 
compressed lung tissue, has been emphasized by 
several authors. 2'16 The advent of video-assisted 
thoracic surgical techniques, in combination with 
laser thoracoscopy, led to application of laser abla- 
tion for both large and more diffuse bul!ous dis- 
ease.6,17 Interpretation of the results of these series 
with respect to the value of such therapy for patients 
with diffuse emphysema remained ifficult, however, 
because of the lack of objective data documenting 
improvement. Recently, the pioneering concepts of 
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Brantigan, Kress, and Mueller 3 have been resur- 
rected, with a median sternotomy technique used to 
achieve bilateral lung reduction for patients with 
diffuse emphysema. 8 This study documented the 
effectiveness of multiple wedge resection to produce 
both symptomatic (dyspnea index) and objective 
(spirometry, 6-minute walk) improvement in pa- 
tients with end-stage mphysema refractory to med- 
ical management. I  remained uncertain, however, 
whether a less invasive video-assisted approach 
could achieve comparable functional results. The 
focus of this study was to evaluate the unilateral 
thorac0scopic procedure for the treatment of pa- 
tients with diffuse emphysema. 
Our initial enthusiasm for the use of laser ablation 
to achieve lung reduction quickly became tempered 
by the discouraging clinical results. Six of the 10 
patients had poor outcome, leading us to abandon 
the laser, except for minor portions of some proce- 
dures, in favor of stapled resection of strips of the 
most severely damaged lung. CT scan with density 
mask imaging to highlight the boundary zones be- 
tween useful and emphysematous ti sue, and the 
quantitative ventilation-perfusion scans with SPECT 
perfusion scintigraphy are crucial in identifying the 
areas to be resected. With these techniques as a 
guide, strips of diseased tissue are resected to re- 
duce the volume of the lung by approximately 25% 
in a way that also tailors the resection to avoid space 
problems at the end of the case. 
Air leakage requiring chest tube placement for 
longer than 5 days was the single most important 
complication, affecting 31 of the 57 patients under- 
going stapled resection. Use of bovine pericardial 
strips to buttress the staple lines, as advocated by 
Cooper, 18 has only recently become practical with 
sets designed for the endoscopic stapling devices. 
Nevertheless, most air leaks sealed within 2 weeks, 
and mean length of stay in the hospital (17 days) was 
similar to that reported after median sternotomy, s 
Acceptance of any technique requires demonstra- 
tion of objective improvement as well as subjective 
benefit. Spirometric values (FEV1, FVC) signifi- 
cantly increased after unilateral thoracoscopic lung 
reduction. In one third of the patients, the extent of 
improvement was in the range achieved with the 
bilateral approach. Lung volume measurements all 
fell after operation, with a disproportionate d cline 
in RV compared with TLC. An improvement in 
inspiratory capacity and therefore FVC was the net 
result of this change. Functional progression i  the 
ability to exercise was demonstrated by the signifi- 
cant improvement in the distances achieved uring 
the 6-minute walk test. Finally, the subjective benefit 
of the operation was suggested by the significant 
improvement in functional impairment, as docu- 
mented by the TDI. This level of improvement 
meant a return to most activities of daily living for 
the majority of patients. 
Potential mechanisms for improvement after lung 
reduction procedures include increases in intrinsic 
elastic recoil and improvement in diaphragmatic 
function. Loss of elastic recoil, resulting in de- 
creased alveolar driving pressure and increased ex- 
piratory resistance, leads to a reduction in the 
expiratory flow rate. With time, these changes lead 
to an increase in lung volumes as expiration is halted 
from premature airway collapse. These expanded 
lung volumes lead to "bowing" of the diaphragm 
and to inadequate generation of inspiratory contrac- 
tile forces of intercostal and diaphragmatic muscles. 
Improvement in elastic recoil would increase the 
driving pressure that generates flow and would also 
reduce airway resistance by tethering the airways. 
Similarly, improved respiratory muscle efficiency 
should result from a reduction in end-expiratory 
lung volumes. Of note, in this study the decline in 
RV was greater than the change in TLC. Under 
these conditions, lung reduction surgery is not "vol- 
ume reduction" because TLC declines only slightly. 
The improvement in the RV/TLC ratio results from 
significant increases in inspiratory capacity and ex- 
piratory reserve volume in the setting of a relatively 
fixed thoracic age. It is likely that FEV1, an unnat- 
ural maneuver equiring maximal effort, does not 
reflect he entire spectrum of improvement resulting 
from improved elastic recoil and decreased lung 
volumes. 
Finally, this study was undertaken to enhance our 
understanding of the preoperative selection criteria 
that best identify the most appropriate candidates. 
Candidates hould have evidence of hyperinflation 
on a chest roentgenogram, with well-demarcated 
areas of trapped air or dead space determined by 
CT scan and ventilation-perfusion SPECT scanning. 
These areas should be associated both with wash-in 
and washout abnormalities and with hypoperfusion. 
In addition, we determined that the combination of 
significant resting hypercapnia (Pco 2 > 50 mm Hg) 
and DLCO less than 25% of predicted was associ- 
ated with an adverse outcome in five of six affected 
patients. Such patients hould not be considered for 
unilateral thoracoscopic lung reduction. 
Lung reduction procedures have the potential to 
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benefit a large group of patients with end-stage 
diffuse emphysema who have exhausted their med- 
ical alternatives. These are patients for whom im- 
proved quality of life is as important as, if not more 
important, than the opportunity to extend life. 
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Discuss ion 
Dr. Alee G. Patterson (St. Louis, Mo.). I am only 
substituting for the inevitable commentary that would 
have been provided by Joel Cooper had he been here. I 
compliment you on the work. It was a clear presentation 
and a lot of interesting data. Those SPECT images are 
fantastic. In how many cases have you used that imaging 
strategy? 
Dr. Keenan. Probably about 40 now. We began to use it 
back in the late summer, and since that time it has been a 
major factor in our assessment. 
Dr. Patterson. We have exclusively used a bilateral 
approach, except in patients with a specific contraindica- 
tion to a bilateral operation such as previous operation or 
radiation. I think our results are approximately 50% 
better than yours. One might expect his difference, given 
the improvement observed after bilateral versus unilateral 
procedures. Are there patients you consider should un- 
dergo a bilateral operation. If so, what is your current 
thought on such indications? 
Dr. Keenan. I agree that the bilateral approach is of 
particular benefit for many patients. Of the total number 
of patients on whom we have performed lung reduction 
operations, we have done probably a dozen or so median 
sternotomies and not quite that many bilateral thoraco- 
scopic approaches. I think the patients that would benefit 
from a bilateral approach from the beginning are those 
with extremely severe evidence of obstructive disease, 
perhaps the ones who have FEV~s of 10% to 15%, as 
opposed to 15% to 25%. I think also that patients who 
have clearly symmetric disease with large areas on both 
sides, particularly both upper lobes, that can be attacked 
at the same time would benefit from a bilateral approach 
right away, as opposed to a unilateral approach. Those are 
the patients that we are now looking at as predominantly 
wanting to do bilateral approaches on. 
We happen to want to explore the whole issue of 
bilateral thoracoscopic approaches, o we do the proce- 
dure as a thoracoscopy, flip the patient over, and do 
another thoracoscopy. Thoracoscopy offers a particularly 
good view of the entire hemithorax, as you know, and 
there may be some advantage in certain people for 
bilateral thoracoscopy as opposed to sternotomy. So I 
think that there will be a group of people, probably the 
worst-off patients, who should undergo the bilateral ap- 
proach-no matter how it is performed--as the first step. 
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I think that many others will obtain not just objective but 
symptomatic mprovement with the unilateral approach. 
Perhaps one of the advantages might be that, with further 
follow-up and rehabilitation, you can then maybe carry the 
patients out a little bit further and then operate on the 
other side and carry them out again. 
Dr. David Johnstone (Rochester, N.Y.). Since you have 
done a fair amount of thoracoscopic emphysema sur- 
gery and now some operations with the sternal ap- 
proach, how do you decide how much lung to resect, 
and how do you assess whether you are going to have an 
air space? Because reexpansion of the lung with the 
video-assisted thoracoscopic surgical approach obliter- 
ates your view, I do not see how you reassess it during 
the operation. 
Dr. Keenan. There has been a lot of discussion on how 
much lung you should resect. People have put arbitrary 
values--25%, 30%--on it. I am not sure how you decide. 
Other people have looked at lung weights, saying you 
should take a certain number of grams of lung tissue. 
Clearly, that is going to be tremendously different between 
patients with air sacs versus those with a diffuse emphy- 
sema that has some substance to it. My approach is to go 
exactly where the SPECT imaging tells me I should go, 
and I do not go anywhere lse. 1 also try to avoid the 
temptation to keep going, always doing a little bit more, 
and try to just restrict myself to what I decided I was going 
to do before operation. It is possible to get some idea of 
the potential for a space problem by periodic reinflation, 
one breath, two breaths at most, just to start seeing that it 
is going to fill up in the areas that you have previously 
resected. By using an endoscopic lung retractor, you can 
get a sense of whether there is a potential for development 
of a space problem. That is what I do. 
